Thus, MM patients carrying germline BAP1 mutations benefit from this information, and their relatives may benefit from screening programs for early cancer detection, when these malignancies can be cured by resection (melanomas) or are more susceptible to therapy (MM and other cancers). The gene discussed is BAP1; the disease is melanoma.